Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment

Area of Science:

• Psychiatry
• Neuroscience
• Developmental Psychology

Background:

• Psychedelic drugs show promise for adult psychiatric conditions, including PTSD and TRD.
• Increasing interest in psychedelic therapies necessitates evaluating their potential use in minors.
• Historical research on psychedelics in children (1959-1974) requires critical review.

Purpose of the Study:

• To examine historical psychedelic research methodologies and ethical considerations in children.
• To propose updated ethics and policy recommendations for psychedelic research involving minors.
• To address the unique challenges of informed consent and potential developmental impacts in pediatric psychedelic research.

Main Methods:

• Review of historical psychedelic research conducted on children between 1959 and 1974.
• Analysis of methodological and ethical shortcomings in past studies.
• Development of recommendations based on historical findings and current ethical standards.

Main Results:

• Historical psychedelic research in children exhibited significant methodological and ethical deficiencies.
• Psychedelic experiences can lead to profound personality changes and affect value systems in developing individuals.
• The ineffable nature of psychedelic experiences complicates informed proxy consent for minors.

Conclusions:

• Ethically sound psychedelic research in minors requires strict eligibility criteria and comprehensive history assessments.
• Development of age-appropriate assent processes, including considerations for therapeutic touch, is crucial.
• Oversight by DSMBs, patient advocates, and pharmacoequity practices are essential for safety and fairness in pediatric psychedelic research.